O'Neill eyes up to $2 billion for fund to fight superbugs

February 26, 2015 5:24 PM

12 0

LONDON (Reuters) - A global fund to speed development of new antibiotics to counter the growing threat of drug-resistant superbugs is likely to need up to $2 billion, the head of a review backed by the British government said on Thursday.

Former Goldman Sachs chief economist Jim O'Neill has urged the establishment of an innovation fund to support research, arguing that far too little is currently invested in hunting for new drugs against drug-resistant infections.

Also read: Supreme Court Declines to Wade Into Fight Over Fannie, Freddie Profits

Read more

To category page